Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
Muscular Dystrophy Association
AddedFeb 15, 2024
UpdatedJun 28, 2026
Muscular Dystrophy Association

Muscular Dystrophy Association

Operating

MDA: An American nonprofit advancing research and care for muscular dystrophy and related diseases.

Founded
1950
Location
Chicago, IL, US
Overview
Compare
Employees
Website

Founded in 1950 by Paul Cohen, the Muscular Dystrophy Association (MDA) is an American nonprofit organization dedicated to supporting individuals affected by muscular dystrophy, ALS, and related neuromuscular diseases. MDA's core mission is to accelerate research, advance care, and empower families to live longer and more independent lives. The organization offers a range of services including funding for scientific research, providing comprehensive healthcare services, and advocating for policies that benefit the neuromuscular disease community.

Notable figures associated with MDA include Jerry Lewis, who hosted the renowned MDA Labor Day Telethon from 1966 to 2010. The telethon significantly raised public awareness and funds for the cause. MDA has achieved numerous milestones in advancing research and treatment options, contributing to groundbreaking discoveries in gene therapy and other innovative treatments. The organization's impact is evident in its extensive support network and its role in improving the quality of life for those affected by neuromuscular diseases.

Muscular Dystrophy Association - Quick Facts

When was Muscular Dystrophy Association founded?

Muscular Dystrophy Association was founded in 1950.

Where is Muscular Dystrophy Association's headquarters located?

Muscular Dystrophy Association's headquarters is located in Chicago, IL, US.

When was Muscular Dystrophy Association's last funding round?

Muscular Dystrophy Association's most recent funding round was for $2.9M (USD) in December 2023.

How much has Muscular Dystrophy Association raised to-date?

As of Dec 18, 2023, Muscular Dystrophy Association has raised a total of $2.9M (USD).

How many employees does Muscular Dystrophy Association have?

Muscular Dystrophy Association has 1,211 employees as of Feb 4, 2024.

Muscular Dystrophy Association - Classification

Ownership
  • Non-profit
Technology
  • HealthTech
Geographic Exposure
  • United States
Customer
  • Consumers
Main Product
  • Healthcare
  • Research
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813200Grantmaking and Giving Services
  • 813210Grantmaking and Giving Services
  • 813212Voluntary Health Organizations
  • 813900Business, Professional, Labor, Political, and Similar Organizations
  • 813920Professional Organizations
  • 810000Other Services (except Public Administration)
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8600Membership Organizations
  • 8620Professional Membership Organizations
  • 8690Membership Organizations, Not Elsewhere Classified